These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34803012)

  • 1. Neurochemical and behavioral effects of fluoxetine on midazolam induce dependence in an animal model of addiction.
    Ikram H; Tasneem S; Perveen S; Zakir R; Jabeen Haleem D
    Pak J Pharm Sci; 2021 Sep; 34(5):1749-1757. PubMed ID: 34803012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and behavioral effects of midazolam: A dose related study.
    Ikram H; Tasneem S; Perveen S; Haleem DJ
    Pak J Pharm Sci; 2020 Jan; 33(1):85-93. PubMed ID: 32122835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and behavioral effects of lorazepam: A dose related study.
    Ikram H; Atique I; Perveen S; Zakir R; Haleem DJ
    Pak J Pharm Sci; 2021 Jan; 34(1):135-141. PubMed ID: 34248013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum.
    Brenes JC; Fornaguera J
    Behav Brain Res; 2009 Mar; 198(1):199-205. PubMed ID: 19027796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.
    Piergies AA; Sweet J; Johnson M; Roth-Schechter BF; Allard S
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):178-83. PubMed ID: 8861737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Rogóż Z; Kabziński M; Sadaj W; Rachwalska P; Gądek-Michalska A
    Pharmacol Rep; 2012; 64(6):1391-9. PubMed ID: 23406749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.
    McNamara RK; Able JA; Liu Y; Jandacek R; Rider T; Tso P; Lipton JW
    Pharmacol Biochem Behav; 2013 Dec; 114-115():1-8. PubMed ID: 24090922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.
    Able JA; Liu Y; Jandacek R; Rider T; Tso P; McNamara RK
    J Psychiatr Res; 2014 Mar; 50():42-50. PubMed ID: 24360505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat.
    Kirby LG; Lucki I
    J Pharmacol Exp Ther; 1997 Aug; 282(2):967-76. PubMed ID: 9262365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats.
    Mendes-da-Silva C; de Souza SL; Barreto-Medeiros JM; de Freitas-Silva SR; Antunes DE; Cunha AD; Ribas VR; de França MF; Nogueira MI; Manhães-de-Castro R
    Arq Neuropsiquiatr; 2002 Dec; 60(4):928-31. PubMed ID: 12563382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeated co-treatment with fluoxetine and amantadine on the behavioral reactivity of the central dopamine and serotonin system in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2009; 61(5):924-9. PubMed ID: 19904017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine.
    Haleem DJ; Farhan M
    Behav Pharmacol; 2015 Feb; 26(1-2):159-66. PubMed ID: 24755891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
    Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
    Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.